Mycoplasma
gallisepticum causes
chronic respiratory disease in chickens leading to large economic
losses in the poultry industry, and the impacts remain to be a great
challenge for a longer period. Among the other approaches, a vaccine
targeting the adhesion proteins of M. gallisepticum would be a promising candidate in controlling the infection. Thus,
the present study is aimed to design a multi-epitope vaccine candidate
using cytoadhesion proteins of M. gallisepticum through an advanced immunoinformatics approach. As a result, the
multi-epitope vaccine was constructed, which comprised potential T-cell
and B-cell binding epitopes with appropriate adjuvants. The designed
multi-epitope vaccine represented high antigenicity with viable physiochemical
properties. The prospective three-dimensional structure of the epitope
was predicted, refined, and validated. The molecular docking analysis
of multi-epitope vaccine candidates with the chicken Toll-like receptor-5
predicted effective binding. Furthermore, codon optimization and in
silico cloning ensured high expression. Thus, the present finding
indicates that the engineered multi-epitope vaccine is structurally
stable and can induce a strong immune response. Furthermore, the multi-epitope
vaccine is suggested to be a suitable vaccine candidate for the M. gallisepticum infection due to its effective binding
capacity and precise specificity.